Discontinue vancomycin and continue ceftriaxone for 10-14 days with dexamethasone for 4 days (Answer D)
The organism is fully susceptible to ceftriaxone (MIC 0.1 μg/mL), making vancomycin unnecessary and potentially harmful if dexamethasone is being used. The penicillin intermediate susceptibility (MIC 0.5 μg/mL) is irrelevant since ceftriaxone remains highly effective.
Rationale for De-escalation
The 2016 UK Joint Specialist Societies guidelines clearly state: "If the pneumococcus is penicillin resistant (MIC > 0.06) but cephalosporin sensitive then cefotaxime or ceftriaxone should be continued" 1. Your isolate meets this exact criterion—penicillin MIC 0.5 μg/mL (intermediate, >0.06) but ceftriaxone MIC 0.1 μg/mL (susceptible, well below the 0.5 μg/mL breakpoint for resistance).
Vancomycin should only be continued when both penicillin AND cephalosporin resistance are present (ceftriaxone MIC >0.5 μg/mL) 1. This is not your scenario.
Critical Issue with Vancomycin + Dexamethasone
Dexamethasone substantially reduces vancomycin CSF penetration, delaying bacterial clearance 2. In experimental models, vancomycin penetration into CSF was "consistently and substantially reduced with dexamethasone treatment, which resulted in a delay in CSF sterilization not observed in non-dexamethasone-treated animals" 2. Since you're appropriately using dexamethasone (which improves outcomes in pneumococcal meningitis 3), continuing vancomycin becomes counterproductive.
The guidelines explicitly warn: "Vancomycin should never be used alone as there are doubts about its penetration into adult CSF, especially if dexamethasone has also been given" 1.
Treatment Duration and Dexamethasone
- Ceftriaxone duration: 10 days if the patient has recovered by day 10; extend to 14 days if recovery is delayed 1
- Dexamethasone: Continue for 4 days total (0.15 mg/kg every 6 hours, started before or with first antibiotic dose) 3
The 2004 IDSA guidelines support adjunctive dexamethasone in adults with bacterial meningitis, showing mortality reduction in pneumococcal cases 3.
Why Not the Other Options?
- Option A (penicillin alone): Inappropriate—penicillin MIC 0.5 μg/mL is intermediate, not fully susceptible (breakpoint ≤0.06 μg/mL for meningitis) 1
- Option B (ceftriaxone alone without specifying duration/dexamethasone): Incomplete answer—doesn't address dexamethasone continuation or vancomycin discontinuation
- Option C (linezolid + gentamicin): No role—organism is ceftriaxone-susceptible; linezolid is reserved for treatment failures 4, 5
- Option E (no change): Suboptimal—exposes patient to unnecessary vancomycin with impaired CSF penetration due to dexamethasone
Common Pitfall
Don't be misled by penicillin intermediate susceptibility. The key susceptibility is to ceftriaxone, not penicillin. Ceftriaxone MIC 0.1 μg/mL is excellent (susceptible breakpoint ≤0.5 μg/mL for meningitis) 1. Recent data confirms that ceftriaxone-susceptible S. pneumoniae meningitis has excellent outcomes with ceftriaxone monotherapy 6.